Anti-cancer treatment within two weeks serves as a risk factor for clinical outcomes among cancer patients with COVID-19
Description
CONCLUSION: Anti-cancer treatments within 2 weeks of COVID-19 infection increase the risk of ICU admission and 30-day mortality after RT-PCR negative conversion in patients with cancer. It may be recommended to postpone cancer-related treatments for
